(A) Key Immune marker expression (TAM markers, TAM related chemokines, T cell markers), TERT and TERC were plotted for fold change of transcript level expression (IL1R1 high / IL1R1 low) and adjusted p-values in breast cancer (BRCA) samples categorized as IL1R1 high or low from TCGA (see Supplementary file 4). This evidence concerns the gene IL1R1 and breast carcinoma.